NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech ... generating company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and ...

Of course, the diversity of the company's opportunities is a good thing, as these three biotech products in development ... enhanced cattle, a living-art and toy company, and a pet-cloning service ...

IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating cancer vaccines based on its T-win ® technology platform, today announced three poster ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq ... A copy of the posters will be added to the Scientific Publications page of the Company’s website at https://nkgenbiotech.com ...

MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing ... 101 clinical trial was accepted for poster presentation at the 2025 Annual ...

Today, biotechnology is no longer the product of most companies that utilize it. Instead, biotechnology is quickly becoming a major methodology for delivering non-biotech products and services in ...

About PCI Biotech PCI Biotech is a biopharmaceutical company ... products. fimaVacc applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines, which ...

PanGIA Biotech, a company advancing urine-based ... biopsy (Abstract #3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly Targeted ...

SANTA ANA, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and ...